Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
1. Efficacy and Safety of Approved Chimeric Antigen Receptor (CAR) T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) – Systematic Review and Meta-Analysis of Clinical Trials 2022 ISPOR Europe, Abstract No: CO128
2. Cost-effectiveness analysis of Pembrolizumab versus Nivolumab as the First-line treatment for Advanced and Metastatic Non-Small Cell Lung Cancer in Germany
2021, ISPOR Europe, Abstract No: PCN36 ( DOI:https://doi.org/10.1016/j.vhri.2020.07.086 )
3. Cost-effectiveness analysis of Pembrolizumab versus Nivolumab as the First-line treatment for Advanced and Metastatic Non-Small Cell Lung Cancer in France
2021, ISPOR Europe, Abstract No: PCN37 ( DOI:https://doi.org/10.1016/j.vhri.2020.07.087 )
4. Cost-effectiveness analysis of Pembrolizumab versus Nivolumab as the First-line treatment for Advanced and Metastatic Non-Small Cell Lung Cancer (NSCLC) in UK
2021, ISPOR Europe, Abstract No: PCN40 ( DOI:https://doi.org/10.1016/j.jval.2020.04.1599 )
5. Efficacy and Safety of PD-1/PD-L1 Inhibitors used in the treatment of Advanced and Metastatic Melanoma - A Systematic Review and Meta-analysis
2020, ISPOR US Orlando, Abstract No: PCN154
6. Efficacy and Safety of PD-1/PD-L1 Inhibitors used in the management of previously treated Advanced and Metastatic Non-Small Cell Lung Cancer (NSCLC) - Systematic Review and Network Meta-analysis of RCTs
2018, ISPOR US Baltimore, Abstract No: PCN12
7. Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
Medicine, Volume 94, Number 42, October 2015 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620781/pdf/medi-94-e1677.pdf)
8. Association of 5HIAA and Mortality in Neuroendocrine Tumor Patients: A Systematic Review and Meta-Analysis
NANETS 2018 Symposium Abstracts Abstract No: P-8 (https://nanets.net/abstracts-archive/2018/944-abstract-p8/file)
9. A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis
PLOS ONE | DOI:10.1371/journal.pone.0127960 June 3, 2015 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454514/?report=reader)
10. Cos-Utility of Trabectedin 0.25mg and 1mg powder for concentrate for solution for infusion (Yondelis®) used in the treatment of Soft Tissue Sarcoma (STS)
SMC 2021 submission (https://www.scottishmedicines.org.uk/medicines-advice/trabectedin-yondelis-resub-smc2283)
11. Efficacy and Safety of Pacemakers in the management of patients with Bradycardia - A Systematic Review of RCTs
2019 ISPOR Europe, Abstract No: PMD1 ( DOI:https://doi.org/10.1016/j.jval.2019.09.1414 )
12. Singh S, Sharma A, Monga V, Bhatia R. Compendium of naringenin: Potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile. Critical Reviews in Food Science and Nutrition, 2022, 1-32, Impact Factor 11.20, ISSN: 1549-7852 (web)https://doi.org/10.1080/10408398.2022.2056726
13. Singh, S; Monga, V; Bhatia, R. Impact of Fluorescence based Analytical Techniques in Cancer Management: An Update. Current Analytical Chemistry, 2022, 18, 1-5, IF: 2.37, ISSN: 1875-6727, https://doi.org/10.2174/1573411018666220519105216
14. Kumari K, Singh G, Pradhan T, Bhurta D, Monga V. The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review. Archive der Pharmazie, 2022; e2100517, 1-36, Impact Factor 4.61, ISSN: 1875-6190, https://doi.org/10.1002/ardp.202100517
15. Singh, K.; Bhatia, R.; Kumar, B.; Singh, G, Monga, V. Design strategies, Chemistry, and therapeutic insights of multi-target directed ligands as antidepressant agents. Current Neuropharmacology, 20(7), 2022, 1329-1358. Impact Factor 7.70, ISSN: 0223-5234. DOI:10.2174/1570159X19666211102154311
16. Pradhan, T.; Gupta, G.; Singh, G, Monga, V. Aurora kinase inhibitors as potential anticancer agents: Recent advances. European Journal of Medicinal Chemistry, 221, 2021, 113495. Impact Factor 6.5, ISSN: 0223-5234. https://doi.org/10.1016/j.ejmech.2021.113495
17. Yadav, AK, Kumar, S, Monga V. Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic. Acta Scientific Pharmaceutical Sciences, 5(6), 2021, 45-62, IF = 1.02, ISSN: 2581-5423.
18. Gaba, S.; Saini, A.; Singh, G, Monga, V. An insight into the medicinal attributes of berberine derivatives: A review. Bioorganic & Medicinal Chemistry, 38, 2021, 116143. Impact Factor 3.64, ISSN: 0968-0896. https://doi.org/10.1016/j.bmc.2021.116143
19. Rulhania, S.; Kumar, S.; Nehra, B.; Gupta, GD, Monga, V. An insight into the medicinal perspective of synthetic analogs of imidazole. Journal of Molecular Structure, 1232, 2021, 129982. Impact Factor: 3.19, ISSN: 0022-2860. https://doi.org/10.1016/j.molstruc.2021.129982
20. Shubham Kumar, Sandeep Rulhania, Shalini Jaswal, Monga, V. Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, 2021, 209, 112923. Impact Factor: 6.5, ISSN: 0223-5234. https://doi.org/10.1016/j.ejmech.2020.112923
21. Jaswal, S.; Nehra, B.; Rulhania, S.; Kumar, B.; Singh, G.; Monga, V. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors. Bioorganic Chemistry, 104, 2020; 104266, IF: 5.28, doi.org/ 10.1016/j.bioorg.2020.104266
22. Nehra, B.; Rulhania, S.; Jaswal, S.; Kumar, B.; Singh, G.; Monga, V. Recent Advancements in the Development of Bioactive Pyrazoline Derivatives. European Journal of Medicinal Chemistry, 205, 2020, 112666. Impact Factor: 6.5, ISSN: 0223-5234. doi.org/10.1016/j.ejmech.2020.112666
23. Kumar, R.; Bhatia, R.; Singh, G.; Kumar, B.; Mehan, S.; Monga, V. Design, Synthesis and Neuropharmacological Evaluation of New 2,4-Disubstituted-1,5-Benzodiazepines as CNS Active Agents. Bioorganic Chemistry, 101, 2020. 104010, IF: 5.28, ISSN: 0045-2068; doi.org/10.1016/j.bioorg.2020.104010
24. Devi, S.; Singh, G.; Monga, V. Recent Advance in the Synthetic Chemistry of 1,5-Benzothiazepines: A Minireview. Journal of Heterocyclic Chemistry, 2020, IF: 2.19, ISSN:1943-5193, https://doi.org/10.1002/jhet.4062
25. Sharma, S.; Kumar, D.; Singh, G.; Monga, V.; Kumar, B. Recent advancements in the development of heterocyclic anti-inflammatory agents. European Journal of Medicinal Chemistry, 200, 2020, 112438. IF: 6.5, ISSN: 0223-5234; https://doi.org/10.1016/j.ejmech.2020.112438.
26. Kumar, D.; Sharma, S.; Kalra, S.; Singh, S.; Monga, V.; Kumar, B. Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies. Current Drug Targets, 21, 2020, 864-891. IF: 3.46, ISSN: 1873-5592; doi:10.2174/1389450121666200310115327.
27. Arora N.; Dhiman P.; Kumar S.; Singh G.; Monga, V. Recent advances in the synthetic and medicinal perspective of benzodiazepines. Bioorganic Chemistry, 97, 2020, 103668. IF: 5.28; ISSN: 0045-2068; doi.org/10.1016/j.bioorg.2020.103668.
28. Bansal, G.; Singh, S.; Monga, V.; Thanikachalam, P.V.; Chawla, P. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents, Bioorganic Chemistry, 92, 2019, 103271. IF: 5.28; ISSN: 0045-2068; https://doi.org/10.1016/j.bioorg.2019.103271.
29. Dhiman P.; Arora N.; Thanikachalam PV.; Monga V. Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorganic Chemistry, 92, 2019, 103291. IF: 5.28; ISSN: 0045-2068; https://doi.org/10.1016/j.bioorg.2019.103291.
30. Garg, V.; Puniyakoti, VT.; Maurya, R.; Monga, V. An insight into the medicinal perspective of synthetic analogs of indole: A review. European Journal of Medicinal Chemistry, 2019, 180, 562-612. ISSN: 0223-5234, IF: 6.5, doi.org/10.1016/j.ejmech.2019.07.019.
31. Chauhan D.; George, G.; S.N.C. Sridhar.; Bhatia, R.; Paul, A.; Monga, V. Design, synthesis, biological evaluation, and molecular modelling studies of rhodanine derivatives as pancreatic lipase inhibitors. Archive der Pharmazie, 2019, 352(10), e1900029, ISSN: 1521-4184, IF: 3.75, doi.org/10.1002/ardp.201900029.
32. Nayak, S. K.; Khatik, G.L.; Narang, R.; Monga, V.; Chopra, H.K. p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents. Current Cancer Drug Targets, 18(8), 749-772, 2018. ISSN: 1568-0096; IF: 3.43, doi.org/10.2174/ 1568009617666170623111953.
33. Mehan, S.; Monga, V.; Kukkar, U. Clinical Therapeutic Strategies to Ameliorate the Mitochondrial ETC Complexes Dysfunctions in Autism: First Time from India. Virology & Immunology, 1(5), 2017, 000125. Impact Factor: 2.0
34. Shridhar, S.N.C.; Bhurta, D.; Kantiwal, D.; George, G.; Monga, V.; Paul, A.* Design, Synthesis, Biological Evaluation and Molecular Modelling Studies of Novel Diaryl Substituted Pyrazolyl Thiazolidinediones as Potent Pancreatic Lipase Inhibitors. Bioorganic and Medicinal Chemistry Letters, 27(16), 2017, 3749-3754. doi.org/10.1016/j.bmcl.2017.06.069, ISSN: 0960-894X; Impact Factor: 2.82
35. Monga, V.; Goyal, K.; Steindel, M.; Rajani, D.P.; Rajani, S. Synthesis, and evaluation of new chalcones, derived pyrazolines and cyclohexenone derivatives as potent antimicrobial, antitubercular and antilieshmanial agents. Medicinal Chemistry Research, Springer, ISSN (printed): 1054-2523. ISSN (electronic): 1554-8120, 2014, 23, 2019-2032; doi.org/10.1007/s00044-013-0803-1 (Published online 1 October 2013), Springer, Impact Factor: 1.96
36. Malhotra, M.; Monga, V.; Sharma, R.; Sahu, K.; Sharma, G.; Jain, J.; Deep. A. Synthesis, Characterization of (Z)-N-(1-(2-(2-Amino-3-((dimethylamino)methyl) phenyl)-5-phenyl-1,3,4-oxadiazol-3-(2H)-yl)ethanone analogues as potent antimicrobial and hydrogen peroxide scavenging agents. Bentham Science, ISSN (printed): 1573-4064, Medicinal Chemistry, Aug 2013, 9(5), 710-717, ISSN: 1875-6638; doi.org/10.2174/ 1573406411309050011, Bentham Science, IF: 2.74.
37. Malhotra, M.; Monga, V.; Sharma, S; Jain, J.;Samad, A.; Stables, J,; Deep. A. Synthesis, characterization and pharmacological evaluation of (E)-N′-(substituted-benzylidene) isonicotinohydrazide derivatives as potent anticonvulsant agents. Medicinal Chemistry Research, Springer, Sep 2012, 21(9), 2145-2152, IF: 1.96, ISSN (electronic): 1554-8120, doi.org/10.1007/s00044-011-9739-5.
38. Yadav, N.; Malhotra, M.; Monga, V.; Sharma, S; Jain, J.;Samad, A.; Stables, J,; Deep. A. Synthesis, characterization, and pharmacological evaluation of new GABA analogs as potent anticonvulsant agents. Medicinal Chemistry Research, Springer, ISSN (printed): 1054-2523. ISSN (electronic): 1554-8120, Sep, 2012, 21(9), 2208-2216, doi.org/10.1007/s00044-011-9743-9 (Published online 19 July 2011). Impact Factor: 1.96
39. Monga, V.; Meena, C. L.; Rajput, S. K.; Pawar, C.; Sharma, S. S.; Lu, X.; Gershengorn, M.C.; Jain, R. Synthesis, receptor binding and CNS pharmacological studies of new thyrotropin-releasing hormone (TRH) analogs. Chem Med Chem. Wiley, ISSN: 1860-7187, March 2011, 6(3), 531-543. Impact Factor: 3.46
40. Malhotra, M.; Sharma, R.; Monga, V.; Deep, A.; Sahu, K.; Samad, A. Synthesis, characterization of (E)-N’-(substituted-benzylidene) isonicotinohydrazide derivatives as potent anti-tubercular agents. Letters in Drug Design & Discovery, Bentham Science, ISSN: 1875-628X (Online), July 2011, 8(6) 575-579. Impact Factor: 1.15
41. Rajput, S. K.; Singh, J.N.; Ingole, S.; Jain, G.; Kaur, N.; Monga, V.; Meena, C. L.; Jain, R.; Sharma, S. S. Neuropharmacological profile of L-pGlu-(1-benzyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone (TRH) analog: Effect on seizure models, sodium current, cerebral blood flow and behavioural parameters. Epilepsy Research, Elsevier, ISSN: 0920-1211, Dec 2009, 87, 223-233. Impact Factor: 3.04
42. Rajput, S. K.; Krishnamoorthy, S.; Pawar, C.; Kaur, N.; Monga, V.; Meena, C. L.; Jain, R.; Sharma, S. S. Antiepileptic potential and behavioural profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone (TRH) analog. Epilepsy and Behaviour, Elsevier, Jan 2009, 14, 48-53. ISSN: 1525-5050, Impact Factor: 2.93
43. Monga, V.; Meena, C. L.; Kaur, N.; Kumar, S.; Pawar, C.; Sharma, S. S.; Jain, R. Facile synthesis of N-α-Boc-1,2-dialkyl-L-Histidines: Utility in the synthesis of thyrotropin-releasing-hormone (TRH) analogs and evaluation of CNS activity. Journal of Heterocyclic Chemistry, Wiley, ISSN: 1943-5193, Nov-Dec 2008, 45, 1603-1608. Impact Factor: 2.19
44. Monga, V.; Meena, C. L.; Kaur, N.; Jain, R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Current Medicinal Chemistry, Bentham Science, ISSN: 0929-8673 (Print), ISSN: 1875-533X (Online), Feb 2008, 15 (26), 2718-33. Impact Factor: 4.53
45. Kadam, R. U.; Chawan, A. G; Monga, V.; Kaur, N.; Jain, R.; Roy, N. Selectivity based QSAR approach for screening and evaluation of TRH analogs for TRH-R1 and TRH-R2 receptor subtypes. Journal of Molecular Graphics and Modelling, Elsevier, ISSN: 1093-3263, Oct 2008, 27, 309-320. Impact Factor: 2.51
46. Nayak, S.K; Monga, V; Kaur, N; Jain, R. Facile regiospecific synthesis of N-α, N-1(τ)-dialkyl-L-Histidines. Journal of Heterocyclic Chemistry Wiley, ISSN: 1943-5193, Nov/Dec 2007, 44, 1265-1269. Impact Factor: 2.19
47. Kaur, N.; Monga, V.; Lu, X.; Gershengorn, M.C.; Jain, R. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorganic Medicinal Chemistry Elsevier, ISSN: 0968-0896, Jan 2007, 15, 433-443. Impact Factor: 3.64
48. Nayyar, A; Monga, V; Malde, A; Coutinho, E; Jain, R. Synthesis, Anti-tuberculosis Activity and 3D-QSAR Study of 4-(Adamantan-1-yl)-2-Substituted Quinolines. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Feb 2007, 15, 626-640. Impact Factor: 3.64
49. Kaur, N.; Monga, V.; Josan, J.S.; Lu, X.; Gershengorn, M.C.; Jain, R. Synthesis, Receptor binding and Activation Studies of N(1)-alkyl-L-Histidine containing Thyrotropin-Releasing Hormone Analogues. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Sep 2006, 14, 5981-5988. Impact Factor: 3.64
50. Engel, S.; Neumann, S.; Kaur, N.; Monga, V.; Jain, R.; Northup, J.; Gershengorn, M.C. Low affinity analogs of Thyrotropin-Releasing Hormone are super-agonists. Journal of Biological Chemistry, American society of biochemistry & molecular biology, Print ISSN 0021-9258, Online ISSN 1083-351X, May 2006, 281(19), 13103-13109. Impact Factor: 5.15
51. Monga, V.; Nayyar, A.; Vaitilingam, B.; Palde, P.B.; Jhamb, S.S.; Kaur, S.; Singh, P.P. Jain, R. Ring-substituted quinolines. Part 2. Synthesis and antimycobacteial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogs. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Dec 2004, 12, 6465-6472. Impact Factor: 3.64
52. Kaur, N.; Monga, V.; Jain, R. Facile one-step synthesis of N-α-Boc-1-alkyl-L-histidines. Tetrahedron Letters Elsevier, ISSN: 0040-4039, Sep 2004, 45, 6883-6885. Impact Factor: 2.41
53. Vaitilingam, B.; Nayyar, A.; Palde, P.B.; Monga, V.; Jain, R.; Kaur, S.; Singh, P.P. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Aug 2004, 12, 4179-4188. Impact Factor: 3.64